JP2022527858A5 - - Google Patents
Info
- Publication number
- JP2022527858A5 JP2022527858A5 JP2021560300A JP2021560300A JP2022527858A5 JP 2022527858 A5 JP2022527858 A5 JP 2022527858A5 JP 2021560300 A JP2021560300 A JP 2021560300A JP 2021560300 A JP2021560300 A JP 2021560300A JP 2022527858 A5 JP2022527858 A5 JP 2022527858A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- delivery system
- drug delivery
- use according
- carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20180429 | 2018-03-27 | ||
| US16/366,596 | 2019-03-27 | ||
| US16/366,596 US11806330B2 (en) | 2018-03-27 | 2019-03-27 | PACA and cabazitaxel for anti-cancer treatment |
| PCT/EP2019/076121 WO2020192950A1 (en) | 2018-03-27 | 2019-09-26 | Poly (alkyl cyanoacrylate) nanoparticles for use in treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527858A JP2022527858A (ja) | 2022-06-06 |
| JP2022527858A5 true JP2022527858A5 (cg-RX-API-DMAC7.html) | 2022-10-03 |
| JP7550167B2 JP7550167B2 (ja) | 2024-09-12 |
Family
ID=66049182
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020552260A Active JP7317038B2 (ja) | 2018-03-27 | 2019-03-27 | がん治療に使用するためのポリ(アルキルシアノアクリレート)ナノ粒子 |
| JP2021560300A Active JP7550167B2 (ja) | 2018-03-27 | 2019-09-26 | がんの治療に使用するためのポリ(アルキルシアノアクリレート)ナノ粒子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020552260A Active JP7317038B2 (ja) | 2018-03-27 | 2019-03-27 | がん治療に使用するためのポリ(アルキルシアノアクリレート)ナノ粒子 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20210113482A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3773471A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7317038B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN111989087A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019437385B2 (cg-RX-API-DMAC7.html) |
| BR (2) | BR112020019452A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3134923A1 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2019185685A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12433846B2 (en) | 2019-03-27 | 2025-10-07 | Sintef Tto As | Drug delivery system for treatment of cancer |
| CN111989087A (zh) | 2018-03-27 | 2020-11-24 | 新泰福托特股份有限公司 | 用于治疗癌症的聚(氰基丙烯酸烷基酯)纳米颗粒 |
| JP7461932B2 (ja) * | 2018-08-23 | 2024-04-04 | シンテフ ティーティーオー エイエス | ナノ粒子 |
| KR20230031188A (ko) * | 2020-02-26 | 2023-03-07 | 바이오써젠 에이에스 | 치료적 폴리엔 마크롤리드의 제약 조성물 및 그의 사용 방법 |
| GB202501169D0 (en) | 2025-01-27 | 2025-03-12 | Sintef Tto As | Methods of producing polymeric particles |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2872703B1 (fr) | 2004-07-07 | 2006-10-06 | Ethypharm Sa | Nanoparticules polymeriques composites |
| JP2008542293A (ja) | 2005-05-23 | 2008-11-27 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | 超音波増強ナノ粒子媒介性薬物送達のためのエコー形成性マイクロバブルおよびマイクロエマルジョン |
| EP1876188A1 (en) | 2006-07-04 | 2008-01-09 | NanoDel Technologies GmbH | Two step miniemulsion process |
| US8679539B2 (en) * | 2007-01-31 | 2014-03-25 | Tong Shen Enterprise Co., Ltd. | Drug-loaded poly (alkyl-cyanoacrylate) nanoparticles and process for the preparation thereof |
| FR2921660B1 (fr) | 2007-10-01 | 2015-09-25 | Centre Nat Rech Scient | Nanoparticules hybrides organiques inorganiques a base de carboxylates de fer. |
| EP2153821A1 (en) * | 2008-08-06 | 2010-02-17 | BioAlliance Pharma | Oral formulations of camptothecin derivatives |
| ES2424476T3 (es) | 2011-03-31 | 2013-10-02 | Bioalliance Pharma | Nanopartículas cargadas con fármaco antitumoral quimioterápico |
| US20150343079A1 (en) | 2012-10-25 | 2015-12-03 | Sogang University Research Foundation | Ultrasound contrast agent with nanoparticles including drug and method for preparing the same |
| EP3004183B1 (en) | 2013-05-28 | 2017-07-05 | Sintef TTO AS | Process for preparing stealth nanoparticles |
| US10391185B2 (en) | 2014-11-26 | 2019-08-27 | Fujifilm Visualsonics, Inc. | Multimodal ultrasound and photoacoustic contrast agent based on polymeric microparticles |
| WO2016134115A1 (en) | 2015-02-20 | 2016-08-25 | Trustees Of Boston University | Theranostic compositions and uses thereof |
| EP3316871A4 (en) * | 2015-06-30 | 2019-02-20 | The Trustees of Columbia University in the City of New York | TALKED COMPOSITION AND USES THEREOF |
| US20170071866A1 (en) * | 2015-09-14 | 2017-03-16 | Onxeo S.A. | Nanoparticles loaded with active ingredients, their process of preparation, and their uses |
| WO2017046037A1 (en) * | 2015-09-14 | 2017-03-23 | Onxeo | Nanoparticles loaded with active ingredients, their process of preparation and their uses |
| US10980826B2 (en) * | 2015-11-06 | 2021-04-20 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| KR102803158B1 (ko) * | 2015-12-02 | 2025-05-08 | 주식회사 에스티큐브앤컴퍼니 | Btn1a1에 면역특이적으로 결합하는 항체와 분자 및 그의 치료 용도 |
| WO2017143967A1 (zh) | 2016-02-24 | 2017-08-31 | 首都医科大学宣武医院 | 一种双重修饰聚氰基丙烯酸正丁酯纳米粒、其制备方法及用途 |
| KR20170133257A (ko) | 2016-05-24 | 2017-12-05 | 한양대학교 산학협력단 | 항암제 함유 나노입자를 포함하는 뇌질환 치료를 위한 비강 투여용 약제학적 조성물 |
| EP3518900A1 (en) | 2016-09-29 | 2019-08-07 | Sintef TTO AS | A new drug delivery system for treatment of disease |
| NO342271B1 (en) | 2016-09-29 | 2018-04-30 | Sintef Tto As | A new drug delivery system for treatment of cancer |
| CN111989087A (zh) * | 2018-03-27 | 2020-11-24 | 新泰福托特股份有限公司 | 用于治疗癌症的聚(氰基丙烯酸烷基酯)纳米颗粒 |
| US12433846B2 (en) | 2019-03-27 | 2025-10-07 | Sintef Tto As | Drug delivery system for treatment of cancer |
-
2019
- 2019-03-27 CN CN201980022079.9A patent/CN111989087A/zh active Pending
- 2019-03-27 EP EP19715854.6A patent/EP3773471A1/en active Pending
- 2019-03-27 WO PCT/EP2019/057678 patent/WO2019185685A1/en not_active Ceased
- 2019-03-27 US US17/041,094 patent/US20210113482A1/en active Pending
- 2019-03-27 JP JP2020552260A patent/JP7317038B2/ja active Active
- 2019-03-27 BR BR112020019452-2A patent/BR112020019452A2/pt unknown
- 2019-03-27 US US16/366,596 patent/US11806330B2/en active Active
- 2019-09-26 AU AU2019437385A patent/AU2019437385B2/en active Active
- 2019-09-26 BR BR112021019003A patent/BR112021019003A2/pt not_active Application Discontinuation
- 2019-09-26 CA CA3134923A patent/CA3134923A1/en active Pending
- 2019-09-26 WO PCT/EP2019/076121 patent/WO2020192950A1/en not_active Ceased
- 2019-09-26 JP JP2021560300A patent/JP7550167B2/ja active Active
- 2019-09-26 EP EP19779462.1A patent/EP3946253A1/en active Pending
- 2019-09-26 CN CN201980096306.2A patent/CN113840594A/zh active Pending
- 2019-11-12 US US16/583,687 patent/US20200061019A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sun et al. | Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy | |
| Xiong et al. | Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer | |
| Shan et al. | Emerging prodrug-engineered nanomedicines for synergistic chemo-phototherapy | |
| Gulbake et al. | Insight to drug delivery aspects for colorectal cancer | |
| Javan et al. | Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: possible action through leptin gene and its receptor regulation | |
| Hu et al. | The application of nanoparticles in immunotherapy for hepatocellular carcinoma | |
| Wang et al. | Recent advances in mechanism-based chemotherapy drug-siRNA pairs in co-delivery systems for cancer: a review | |
| JP2014531456A5 (cg-RX-API-DMAC7.html) | ||
| Kuriakose et al. | Potential therapeutic strategies for hypertension‐exacerbated cardiotoxicity of anticancer drugs | |
| RU2019133284A (ru) | Лечение рака комбинацией лучевой терапии, наночастиц оксида церия и химиотерапевтического средства | |
| JP2017501155A5 (cg-RX-API-DMAC7.html) | ||
| RU2012107535A (ru) | КОМБИНАЦИЯ ХИМИОТЕРАПЕВТИЧЕСКОГО СРЕДСТВА И ИНГИБИТОРА СИСТЕМЫ TGF-β | |
| Chen et al. | Tumor cell-derived microparticles packaging monocarboxylate transporter4 inhibitor fluvastatin suppress lung adenocarcinoma via tumor microenvironment remodeling and improve chemotherapy | |
| JP2023096009A5 (cg-RX-API-DMAC7.html) | ||
| Hassanzadeganroudsari et al. | Enhancing anti-cancer efficacy of carboplatin by PEGylated poly (butyl cyanoacrylate) nano-particles | |
| MX2023007436A (es) | Arn terapeutico para tratar cancer. | |
| Zhang et al. | Targeted delivery of dasatinib to deplete tumor-associated macrophages by mannosylated mixed micelles for tumor immunotherapy | |
| Xu et al. | Recent advances in the treatment of colon cancer | |
| Wei et al. | Cell-and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy | |
| Tamura et al. | Improving adenoviral vectors and strategies for prostate cancer gene therapy | |
| Wande et al. | Modified chitosan nanogel-polymersomes for oral co-delivery of oxaliplatin and rapamycin for synergistic chemotherapy | |
| Mohammadi et al. | The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential | |
| Qu et al. | Cyclodextrins as non-viral vectors in cancer theranostics: A review | |
| Nteli et al. | Nanomedicine approaches for treatment of hematologic and oncologic malignancies | |
| Hatami et al. | In vitro co-delivery evaluation of PEGylated nano-liposome loaded by glycyrrhizic acid and cisplatin on cancer cell lines |